Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aortic Valve Stenosis and Myocardial Efficiency – a Prognostic Marker and a Target for Intervention?
2013-001147-31Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of carvedilol in aortic stenosis (AS) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Myocardial efficiency. Started Jun 2013; status: completed.
02
Drugs
carvedilol
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2013-001147-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001147-31.